These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8696447)
1. The plasma turnover of transfused antithrombin concentrate in patients with acquired antithrombin deficiency. Harper PL; Park GR; Carrell RW Transfus Med; 1996 Mar; 6(1):45-50. PubMed ID: 8696447 [TBL] [Abstract][Full Text] [Related]
2. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group. Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072 [TBL] [Abstract][Full Text] [Related]
3. Antithrombin III transfusion in patients with hepatic cirrhosis. Schipper HG; ten Cate JW Br J Haematol; 1982 Sep; 52(1):25-33. PubMed ID: 7115627 [TBL] [Abstract][Full Text] [Related]
4. Elimination of antithrombin III concentrate in healthy pregnant and preeclamptic women with an acquired antithrombin III deficiency. Weiner CP; Herrig JE; Pelzer GD; Heilskov J Thromb Res; 1990 May; 58(4):395-401. PubMed ID: 2353344 [TBL] [Abstract][Full Text] [Related]
6. Effective prophylaxis of thrombosis by antithrombin III concentrate in a pregnant woman with congenital antithrombin III deficiency: relations between plasma antithrombin III activity and the plasma levels of hemostatic molecular markers. Inomoto T; Takamoto M; Tamura R; Maegawa M; Kamada M; Takayanagi M Haemostasis; 1991; 21(3):147-54. PubMed ID: 1773985 [TBL] [Abstract][Full Text] [Related]
7. Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency--a feasibility pilot study. Kreuz WD; Schneider W; Nowak-Göttl U Eur J Pediatr; 1999 Dec; 158 Suppl 3():S187-91. PubMed ID: 10650867 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes. Kario K; Matsuo T; Kodama K; Matsuo M Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607 [TBL] [Abstract][Full Text] [Related]
9. Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate. Büller HR; ten Cate JW Am J Med; 1989 Sep; 87(3B):44S-48S. PubMed ID: 2679070 [TBL] [Abstract][Full Text] [Related]
10. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency]. Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830 [TBL] [Abstract][Full Text] [Related]
11. The transient increase of plasma thrombin-antithrombin III (TAT) complex levels in patients with congenital antithrombin III deficiency during antithrombin III administration is due to extraction of thrombin from fibrin. Kario K; Matsuo T; Kabayashi H; Matsuo M; Yamamoto K Thromb Res; 1991 Aug; 63(4):469-72. PubMed ID: 1755000 [No Abstract] [Full Text] [Related]
13. Treatment of congenital antithrombin III deficiency with concentrates. Mannucci PM; Boyer C; Wolf M; Tripodi A; Larrieu MJ Br J Haematol; 1982 Mar; 50(3):531-5. PubMed ID: 7066204 [TBL] [Abstract][Full Text] [Related]
14. Initial experience with recombinant antithrombin to treat antithrombin deficiency in patients on extracorporeal membrane oxygenation. Niimi KS; Fanning JJ J Extra Corpor Technol; 2014 Mar; 46(1):84-90. PubMed ID: 24779124 [TBL] [Abstract][Full Text] [Related]
15. Observations during the treatment of antithrombin-III deficient women with heparin and antithrombin concentrate during pregnancy, parturition, and abortion. Brandt P Thromb Res; 1981 Apr 1-15; 22(1-2):15-24. PubMed ID: 7292437 [TBL] [Abstract][Full Text] [Related]
16. Transfusion studies in patients with familial antithrombin III (ATIII) deficiency: half-disappearance time of infused ATIII and influence of such infusion on platelet life-span. Winter JH; Fenech A; Bennett B; Douglas AS Br J Haematol; 1981 Nov; 49(3):449-53. PubMed ID: 7295588 [TBL] [Abstract][Full Text] [Related]
17. Treatment with AT III concentrates in hereditary and acquired AT III deficiency. Gromnica-Ihle E; Ziemer S Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):307-13. PubMed ID: 2465221 [TBL] [Abstract][Full Text] [Related]
19. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders]. Schramm W Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group. Menache D; O'Malley JP; Schorr JB; Wagner B; Williams C; Alving BM; Ballard JO; Goodnight SH; Hathaway WE; Hultin MB Blood; 1990 Jan; 75(1):33-9. PubMed ID: 2403821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]